Chromosome studies of a malignant lymphoma of the brain were made by G-, Q-, and C-banding techniques and by autoradiography. The tumor had a modal chromosome number of 47 and contained 4 markers: 1q-, 6p+, 11q+, and 14q+. A 14q+ marker chromosome frequently seen in malignant lymphomas was identified as a translocation between chromosomes No. 1 and 14 in this case. Although the banding pattern did not reveal abnormalities in chromosomes No. 22, the late replication of one chromosome No. 22 was detected by autoradiography. The abnormality of chromosomes No. 14 and 22 was discussed in relation to its occurrence in brain tumors, and the application of autoradiography in addition to banding techniques was stressed as necessary in cytogenetic studies of tumor chromosomes.
Amylase activity detected in thyroid extracts was significantly higher than that of normal sera. A starch film technique revealed the existence of amylase activity in the follicular lumen and on the follicular epithelia. By electrophoretic analysis of thyroid extracts, 4 bands of amylase activity were observed, one being of the same mobility as parotid and the other 3 more anodic. Amylase extracted from the thyroid appeared in the same position as pancreatic or parotid amylase on Sephadex G75 gel filtration. The possibility is discussed that the thyroid may synthesize amylase of salivary type, which is secreted from the follicular epithelia into the follicular lumen, where it may be transformed into anionic forms.
Summary
An autopsy case of a 27 year old male with gigantic heart of unknown etiology and with evidence of familial occurrence, which might be classified to “familial cardiomegaly” (EVANS) was reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.